- Home
- NVO vs TMUS Comparison
NVO vs TMUS Comparison
Compare NVO & TMUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVO
- TMUS
- Stock Information
- Founded
- NVO 1923
- TMUS 1994
- Country
- NVO Denmark
- TMUS United States
- Employees
- NVO N/A
- TMUS N/A
- Industry
- NVO Biotechnology: Biological Products (No Diagnostic Substances)
- TMUS Telecommunications Equipment
- Sector
- NVO Health Care
- TMUS Telecommunications
- Exchange
- NVO Nasdaq
- TMUS Nasdaq
- Market Cap
- NVO 278.0B
- TMUS 264.8B
- IPO Year
- NVO N/A
- TMUS N/A
- Fundamental
- Price
- NVO $55.81
- TMUS $239.56
- Analyst Decision
- NVO Buy
- TMUS Buy
- Analyst Count
- NVO 7
- TMUS 23
- Target Price
- NVO $98.00
- TMUS $257.98
- AVG Volume (30 Days)
- NVO 14.9M
- TMUS 4.0M
- Earning Date
- NVO 11-05-2025
- TMUS 10-23-2025
- Dividend Yield
- NVO 2.24%
- TMUS 1.46%
- EPS Growth
- NVO 24.25
- TMUS 32.79
- EPS
- NVO 3.93
- TMUS 10.59
- Revenue
- NVO $49,108,936,497.00
- TMUS $84,052,000,000.00
- Revenue This Year
- NVO $10.01
- TMUS $8.80
- Revenue Next Year
- NVO $9.93
- TMUS $5.42
- P/E Ratio
- NVO $13.90
- TMUS $22.82
- Revenue Growth
- NVO 20.91
- TMUS 6.27
- 52 Week Low
- NVO $45.05
- TMUS $195.47
- 52 Week High
- NVO $138.22
- TMUS $276.49
- Technical
- Relative Strength Index (RSI)
- NVO 51.25
- TMUS 37.11
- Support Level
- NVO $53.55
- TMUS $238.50
- Resistance Level
- NVO $55.24
- TMUS $256.69
- Average True Range (ATR)
- NVO 1.13
- TMUS 4.37
- MACD
- NVO 0.24
- TMUS -2.02
- Stochastic Oscillator
- NVO 69.52
- TMUS 7.57
About NVO Novo Nordisk A/S
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About TMUS T-Mobile US Inc.
Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, and that firm merged with Sprint in 2020, creating the second-largest wireless carrier in the US. T-Mobile now serves 80 million postpaid and 25 million prepaid phone customers, equal to around 30% of the US retail wireless market. The firm entered the fixed-wireless broadband market aggressively in 2021 and now serves 7 million residential and business customers. In addition, T-Mobile provides wholesale services to resellers.